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THE EFFECTS OF BENZ O(A)PYRENE AND DIMETHYLBENZANTHRACENE ON
CULTUREDPORCINE AORTIC ENDOTHELIAL FUNCTION
Michelle Lynn Kagey, M.S.
Western Michigan University, 1996
Polycyclic aromatic hydrocarbons are environmental contaminants which
have been shown to initiate and promote atherosclerosis and carcinogenesis in
various animal species. These findings have been based primarily on the increase in
incidence and size of smooth muscle cell tumors in these animals when exposed to
benzo(a)pyrene (BaP) or dimethylbenzanthracene (DMBA).

The endothelium has

also been identified as an important mediator in vascular disease and atherogenesis,
although the endothelial response to these PAHs has not been investigated. Thus, the
focus of this study was on characterization of the endothelial response to BaP and
DMBA. Concentration/response relationships for these chemicals were examined, in
addition to evaluation of cellular toxicity and functional changes induced by BaP and
DMBA which may suggest a role in the atherogenic process.
In this study, the effects of BaP and DMBA on endothelial morphology, cell
proliferation, protein synthesis, monolayer permeability, LDL uptake, and monocyte
adherence were characterized. Results indicate that BaP and DMBA are capable of
inducing morphological changes as well as changes in cell proliferation and protein
content that are time and concentration dependent. Results from functional studies
indicate that although neither BaP or DMBA appear to have an effect on monolayer
permeability, both chemicals are capable of inducing an increase in LDL uptake and
monocyte adherence. Therefore, these results suggest that BaP and DMBA can induce
an endothelial response, and may play a role in the atherogenesis.

TABLE OF CONTENTS
ACKNOWLEOOMENTS ...............................................................................................

ii

LIST OF FIGURES .....................................................................................................

Vi

INTRODUCTION ............... .........................................................................................

1

Endothelial Cell Biology .................................................................................

1

Structure of the Endothelial Monolayer................................................

2

Regulatory Functions of the Endothelium .............................................

3

Regulation of Permeability...................................................................

3

Regulation of Hemostasis.......................................................................

4

Regulation of Vascular Tone and Vascular Cell Growth.........................

5

Other Regulatory Processes..................................................................

6

Atherosclerosis ..............................................................................................

8

Fatty Streak Formation.........................................................................

8

The Intermediate or Fibrofatty Lesion..................................................

1 0

The Fibrous Plaque................................................................................

1 1

Risk Factors and Protective Factors.....................................................

1 1

Polycyclic Aromatic Hydrocarbons................................................................

12

PAH Metabolism ....................................................................................

1 2

PAH Toxicity..........................................................................................

14

REVIEW OF RELATED L ITERATURE..........................................................................

1 6

Role of the Endothelium in LDL Uptake..........................................................

1 6

Role of the Endothelium in Monocyte Adhesion ..............................................

17

Selectins................................................................................................

1 8

lmmunoglobulin-like Molecules...........................................................

19

iii

Table of Contents-continued
lntegrins................................................................................................

1 9

Role of the Endothelium in Monolayer Permeability.....................................

2O

Objectives of the Study...................................................................................

21

Significance of the Study.............................................,..................................

22

MATERIALS AND METHODS......................................................................................

24

Cell Culture and Chemical Administration.....................................................

24

Cell Culture...........................................................................................

24

Chemical Preparation and Administration............................................

25

General Toxicity Assays.................................................................................

25

Morphology............................................................................................

25

Cell Number ..........................................................................................

26

Protein Content .....................................................................................

26

Lactate Dehydrogenase Release..............................................................

27

Cell Proliferation/DNA Synthesis........................................................

27

Colony Formation ..................................................................................

28

Functional Studies..........................................................................................

28

Low-density Lipoprotein (LDL) Uptake...............................................

28

Monolayer Permeability.......................................................................

29

Monocyte Adherence ..............................................................................

30

Statistical Analysis...............................................................................

31

RESULTS..................................................................................................................

32

General Toxicity Assays.................................................................................

32

Morphology............................................................................................

32

Cell Number ..........................................................................................

33

iv

Table of Contents-continued
Protein Content .....................................................................................

35

LDH Release...........................................................................................

38

DNA Synthesis .......................................................................................

3' 81

Colony Formation ...................................................................................

41

Functional Studies..........................................................................................

43

Low-density Lipoprotein Uptake..........................................................

43

Monolayer Permeability.......................................................................

45

Monocyte Adherence ..............................................................................

46

DISCUSSION.............................................................................................................

49

BIBLIOGRAPHY........................................................................................................

61

V

LIST OF FIGURES
1.

Cellular Composition of the Vascular Wall of Medium and Large Sized
Blood Vessels ..................................................................................................

1

2.

Porcine Aortic Endothelium in Vitro ............................................................

2

3.

Endothelial Regulated Hemostasis ..................................................................

5

4.

Fatty Streak Development..............................................................................

9

5.

Chemical Structures of Anthracene, Benzo(a)pyrene, and 7,12Dimethylbenzanthracene................................................................................

13

6.

Treatment-Induced Morphological Changes in Cultured Porcine Aortic
Endothelium....................................................................................................

33

7.

The Effects of BaP on Endothelial Cell Number..............................................

34

8.

The Effects of DMBA on Endothelial Cell Number..........................................

35

9.

The Effects of BaP on Total EC Protein...........................................................

36

1 O.

The Effects of DMBA on Total EC Protein.......................................................

37

11.

The Effects of BaP on DNA Synthesis..............................................................

39

1 2.

The Effects of DMBA on DNA Synthesis ...................... . ................... ................

40

1 3.

Colony Forming Efficiency of Cells Treated With BaP or DMBA.. .................

42

1 4.

LDL Uptake of Cells Treated With BaP..........................................................

44

15.

LDL Uptake of Cells Treated With DMBA........................................................

44

16.

The Effects of BaP on Endothelial Cell Monolayer Permeability to
Albumin..........................................................................................................

45

1 7.

The Effects of DMBA on Endothelial Cell Monolayer Permeability to
Albumin..........................................................................................................

46

1 8.

The Effect of BaP on Monocyte Adherence to Endothelial Cells ......................

47

1 9.

The Effect of DMBA on Monocyte Adherence to Endothelial Cells...................

48

vi

INTRODUCTION
Endothelial Cell Biology
The endothelium, which comprises the interface between the blood and the
underlying vessel wall (Figure 1), is a powerful mediator of signals and blood
components between the circulation and the tissues supplied by these vessels.
Existing as a monolayer, the vascular endothelium was previously thought to be
nothing more than a metabolically inert, selectively permeable barrier between the
blood and tissue spaces (Pearson, 1991; Fajardo, 1989; van Hinsbergh, 1992).

In

recent years, however, it has been discovered that the endothelium is a critical
factor in the regulation of vascular hemostasis, vascular tone, angiogenesis,
macromolecular transport, response to mechanical stresses, and disease processes.
Circulating Blood
subendothe I ia I Iayer: connective and e I astic tissues

-- Endothe I ia I Mono I ayer
Tunica Intima

'==3

Tunica Media
Tunica Adventitia
Smooth Muscle eel Is,
collagen, elastin

Figure 1.

Fibroblasts, collagen,
elastin,
glycosaminoglycans

Cellular Composition of the Vascular Wall of Medium and Large Sized
Blood Vessels.
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Structure of the Endothelial Monolayer
The endothelium consists of a single layer of polygonal, flattened cells which
line the luminal surface of the blood vessel wall.

These cells typically display a

cobblestone-like morphology, and retain this appearance in culture (Figure 2). The
luminal surface of the endothelium is covered with a carbohydrate-abundant
glycocalyx while the abluminal surface is anchored to the subendothelial matrix via
binding proteins known as integrins, which are also responsible for intercellular
adhesion of endothelial cells (Alberts et al., 1994).

The subendothelial matrix is

synthesized by the endothelium and consists of collagen, elastin, laminin, and
fibronectin.

Each of these matrix components have specific influences upon cell

migration and proliferation as does the cytoskeleton (Alberts et al., 1994). In vivo
and in vitro, under simulated conditions of blood flow and shear stress (Davies and
Tripathi, 1993), endothelial monolayers align themselves longitudinally in the
direction of blood flow.

It is believed that this is accomplished by transducing

physical forces into biochemical signals which then act upon the proteins of the
extracellular matrix and with the microfilaments of the cytoskeleton (Davies and
Tripathi,

Figure 2.

1993).

Porcine Aortic Endothelium in Vitro. 40 x magnification. Stained with
0.5% crystal violet.

3
Endothelial monolayers are heterogeneous; individual cell size ranges from
10 µ to 50 µ in diameter and from 0.1 µ to 0.5 µ in thickness.

Depending upon

location, endothelial monolayers may be continuous (without pores; CNS, lung,
muscle, skin), sinusoidal (irregular, large gaps between cells; liver, bone marrow,
spleen), or fenestrated (with pores/fenestrae; intestinal mucosa, endocrine glands,
and

renal

glomerulus)(Leeson

et al., 1988; Fajardo, 1989).

In addition,

intercellular junctions vary with cell location; occludens, adherens, and gap
junctions are found in some but not all endothelial monolayers (e.g., gap junctions
are not found in the capillaries) (Leeson et al., 1988).
Regulatory Functions of the Endothelium
The endothelium is now known to play a role in the regulation of vascular
permeability, hemostasis, vascular tone, vascular cell growth, the expression of
various receptors and binding sites, the secretion of specific proteins, the response
to inflammatory stimuli, and angiogenesis (van Hinsbergh, 1992).

Precise

regulation of these processes is necessary for vascular homeostasis; alterations in
this regulatory balance may lead to vascular disease and dysfunction.
Regulation of Permeability
The selectively permeable barrier provided by the endothelial monolayer
consists of several pathways through which fluids, solutes, and macromolecules can
pass from the lumen of the vessel into the subendothelial space. Small molecules
such as oxygen are able to diffuse across the plasma membrane, while small lipids
are able to pass into the subendothelial space via lateral movement across the
membrane at intercellular junctions and transendothelial channels (van Hinsbergh,
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1992).

Solute exchange occurs passively through the cell membrane, through

vesicles, through small and large pores of the cell, and via passage through
intercellular junctions.

Macromolecules rely upon carrier mediated exchange and

receptor mediated transport (van Hinsbergh, 1992), while cellular components and
many toxic substances are prevented from crossing the endothelial barrier.
Injury to the endothelium may cause a loss of cells from the monolayer,
resulting in increased permeability and interstitial edema.

In non-denuding injury

due to reactive oxygen species or chemicals, changes in the cytoskeleton may occur,
leading to enhanced permeability between cells (Coomber and Gotlieb, 1990). The
endothelium must attempt to correct an increase in permeability by increasing cell
migration and proliferation such that intercelluar junctions may be reestablished.
Regulation of Hemostasis
The endothelium is also involved in maintaining balance between a
procoagulant and an anticoagulant state. The intact endothelium maintains a shift
towards the anticoagulant state via the production of proteins which inhibit
coagulation, platelet aggregation, and vasoconstriction, and which trigger the
fibrinolysis pathway (van Hinsbergh, 1992).

Endothelial injury may result in a

shift towards the procoagulant state and is accompanied by platelet aggregation.
However, a spontaneous shift towards this state can cause thrombus formation,
resulting in tissue ischemia due to obstruction of blood flow (van Hinsbergh, 1992).
Figure 3 illustrates some of the specific factors involved in endothelial regulated
hemostasis.
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endothelial cell. (Nachman and Hajjar,1991).

Regulation of Vascular Tone and Vascular Cell Growth
Endothelial cells contribute to the regulation of smooth muscle contraction in
the vessel wall via the release, catabolism, and conversion of vasoconstrictor and
vasorelaxing substances. Examples of chemical conversion to vasoactive substances
include the catabolism of ATP and ADP into AMP and adenosine, a potent vasodilator
(van Hinsbergh, 1992); angiotensin I is converted by angiotensin converting
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enzyme (ACE) into angiotensin II, a potent vasoconstrictor (van Hinsbergh, 1992).
EDRF (endothelial derived relaxing factor) production can be induced by
acetylcholine, histamine, bradykinin, substance P, and ATP. EDRF (also known as
nitric oxide) then activates guanylate cyclase leading to cGMP production in vascular
smooth muscle cells (VSMC), thus inducing relaxation (van Hinsbergh, 1992;
Fajardo, 1989).

Prostacyclin and prostaglandins are induced by the same

mediators, but induce relaxation through activation of adenylate cyclase leading to
cAMP production.

It has also been suggested that endothelial mechanoreceptors

responding to shear/mechanical stress induce the generation of vasoactive mediators
within the endothelium (Davies and Tripathi, 1993).
In addition, some of these factors have been found to have an effect upon VSMC
growth. Recent reports suggest that vasoconstrictors such as endothelin-1 promote
VSMC growth, while vasorelaxant substances such as nitric oxide (endothelial
derived relaxing factor; EDRF) or prostacyclin tend to inhibit VSMC growth (Peiro,
et al., 1995). VSMC growth is also regulated by the quiescent endothelium and its
matrix.

Therefore, poor regulation of vasoactivity may lead to chronic

vasoconstriction and hypertension, in addition to excessive VSMC division, resulting
in a pathological condition.
Other Regulatory Processes
In addition to the regulation of permeability, hemostasis, vasoactivity and
vascular cell growth, the endothelium is also actively involved in the response to
inflammatory stimuli and angiogenesis.
(interleukin-1,

tumor

necrosis

Inflammatory mediators in the circulation

factor,

interferon

gamma,

bacterial

lipopolysaccharide) are capable of activating protein synthesis within the
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endothelium, although this ability decreases with age and senescence of the
endothelium

in vitro (Klein, et al., 1995).

Among the induced proteins are

leukocyte adhesion molecules ELAM-1, VCAM-1, and ICAM-1, in addition to
plasminogen activator inhibitor-1, tissue factor, MHC class I antigens, NO synthase,
and cyclooxygenase. The effect of an acute inflammatory response by the endothelium
can lead to increased intercellular permeability (via histamine and bradykinin
binding to endothelial receptors (Pearson, 1991)) and edema; increased leukocyte
adherence can result in extravasation of monocytes in to the subendothelium and
subsequent formation of lipid laden foam cells. Thus, the induction of these proteins
in response to inflammation has been found to contribute to the acceleration of
atherosclerosis (van Hinsbergh, 1992).
Angiogenesis, the process of new vessel development, is also attributed to the
endothelium.

Under normal conditions, endothelial cell turnover in an intact

monolayer is slow (due to the presence of inhibitory signals from neighboring
pericytes), but in conditions of vascular disease or in wound healing the endothelium
responds to angiogenic stimuli such as fibroblast growth factor, epidermal growth
factor, and prostaglandins (Pearson, 1991).

The angiogenic response induces the

secretion of proteolytic enzymes from the endothelium (Pearson, 1991) which
degrade the endothelial matrix components.

The endothelial cells then migrate in

response to chemotactic angiogenic factors where they form neovessels through
replication and remodeling (Fajardo, 1989).
Thus, the endothelium is a critical factor in the maintenance of vascular
homeostasis.

Any defect in the endothelial regulation of vascular permeability,

hemostasis, vascular tone, cell growth, angiogenesis, or the inflammatory response
may result in vascular dysfunction and/or vascular disease.

Elucidating the role of

the endothelium in vascular disease processes such as atherosclerosis is therefore

8

essential to the understanding of the disease process as well as for the development of
preventive measures and therapeutic targets.

Atherosclerosis
Atherosclerosis is a progressive disease initially. affecting the intimal region
of the medium and large vessels of the cardiovascular system, and ultimately
inducing plaque and thrombus formation, occlusion of the vessel lumen, and focal
degeneration of the vessel wall.

Atherosclerosis contributes to virtually every form

of cardiovascular disease, making it one of the leading causes of death in the United
States.

Once considered to be a consequence of aging, atherosclerosis is now

understood to be a condition of chronic focal inflammation which may be induced or
enhanced by various environmental, physiological, and chemical factors (Ross,
1993; Davies and Woolf, 1993). Such factors include elevated cholesterol and blood
pressure, cigarette smoke, sex, weight, and heredity.
Fatty Streak Formation
The first stage in atherogenesis is the development of the fatty streak within
the intima of the vessel wall (Figure 4).

Once thought to be an inactive barrier

between the blood and vessel wall, the endothelium is now understood to be actively
involved in this disease process, as well as in vascular homeostasis.

Lesion

development is thought to begin with an alteration in normal endothelial function
generally due to endothelial injury (i.e., in response to toxins, viruses, mechanical
injury, or oxidized low density lipoprotein (oxLDL)).

The result is an 'activated'

endothelial cell which produces leukocyte adhesion molecules, monocytic activators,
oxygen free radicals, mitogens and chemoattractants for smooth muscle cells, and
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generally displays an increase in monolayer permeability (DiCorleto and Chisolm,
1986; Gimbrone, 1995; Ross, 1995; Nawroth et al., 1993).

LDL
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Figure 4.
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Fatty Streak Development. ROI: reactive oxygen intermediates. CAM:
Cellular adhesion molecules. Adapted from Berliner et al., 1995.

Under normal conditions, the endothelium internalizes LDL via receptor
mediated endocytosis on coated pits, such that LDL can be utilized for membrane
synthesis.

Under conditions of endothelial activation, internalized LDL may be

oxidatively modified within the cell where it may exert cytotoxic effects (Berliner et
al, 1995; Ross 1993).

Alternatively, the increased permeability of an activated

endothelial monolayer allows movement of LDL from the circulation into the
subendothelial space where it becomes trapped as a result of intimate association
with the subendothelial matrix (Berliner et al, 1995).

Here, the LDL is susceptible

to oxidative modification by reactive oxygen intermediates secreted from various
pathways within the cells of the arterial wall (Ross 1993).

OxLDL in the

subendothelial space induces the expression of adhesive glycoproteins (ICAM-1,
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VCAM-1) on the luminal side of the endothelium and endothelial secretion of
chemotactic molecules, resulting in the migration and adherence of monocytes to the
endothelial cell surface.

The chemotactic effects are mediated in part by

lysophosphatidylcholine, which is formed during the oxidation of native LDL (Penn
and Chisolm, 1994).

The induction of endothelial monocyte chemotactic protein-1

(MCP-1) by oxLDL induces transendothelial migration of the monocytes at the
intercellular junctions into the subendothelial space.

Here, monocytes differentiate

into macrophages in response to oxLDL-induced endothelial production of macrophage
colony stimulating factor (M-CSF).

Oxidized lipid in the subendothelial space is

avidly ingested by subendothelial macrophages via scavenger receptors which are not
down regulated by intracellular lipid (Davies and Woolf, 1993) such that the
macrophages become engorged with lipid and take on a 'foam cell' appearance. These
cells constitute the bulk of the fatty streak within the vessel intima, and are
commonly found at sites of turbulent flow such as the bifurcations and curves.
The Intermediate or Fibrofatty Lesion
The lesion known as the fatty streak may regress, or under appropriate
conditions may progress to a fibrofatty lesion.

Following the formation of the fatty

streak, lipid laden foam cells secrete smooth muscle growth factors and chemotactic
molecules resulting in smooth muscle cell proliferation and infiltration into the
intima.

Further progression results in the formation of a necrotic core within the

lesion; this core consists of extracellular lipid that has been released from dying
foam cells (Davies and Woolf, 1993).

Simultaneous production of excessive

extracellular matrix components (collagen, elastin, and proteoglycans) occurs,
contributing to the size of the lesion such that it begins pushing towards the
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adventitia until it can no longer expand (Davies and Woolf, 1993).
The Fibrous Plaque
The fibrous plaque is the most advanced lesion in the atherosclerotic process.
At this stage connective tissue has infiltrated the lesion, forming a fibrous cap which
provides stability to the lesion. The cap covers the necrotic core which by this time
contains macrophages, T lymphocytes, and smooth muscle cells in addition to lipid
(Ross, 1995). The size of the plaque prevents further expansion into the intima and
thus begins to protrude into the vessel lumen. Calcification of the plaque occurs and
predisposes the plaque to rupture; reduced strength of the tissue as a result of the
lesion may also play a role in plaque rupture (Davis and Woolf, 1993).

As the

plaque tears, blood is able to enter from the lumen and comes into contact with
collagen and tissue factor (expressed in the adventitia) and thrombus formation
ensues (Berliner et al., 1995). Thrombus formation may be mural or occluding in
nature; mural thrombi exist within the torn plaque, consist primarily of platelets,
and do not protrude further into the vessel lumen although they contribute to
stenosis (Davis and Woolf, 1993).

Occluding thrombi exist both within the plaque

and the lumen, consist of both platelets and fibrin, and may obstruct blood flow thus
leading to a clinical event (Davis and Woolf, 1993).
Risk Factors and Protective Factors
High-density lipoprotein (HDL} has been found to play a protective role in
preventing fatty streak formation. HDL has been found to inhibit the oxidation of LDL
by metal ions both in vivo and in vitro as a result of the HDL associated enzymes
platelet activating factor acetylhydrolase and paraoxonase (Navab et al., 1995).

1 2

Thus HDL is capable of preventing some of the secondary effects of LDL oxidation,
such as the induction of MCP-1 (monocyte chemotactic protein-1) and the
subsequent infiltration of monocytes into the subendothelial space. In contrast, there
are several risk factors associated with the progression of the atherosclerotic
process including elevated blood cholesterol levels, high blood pressure, and
cigarette smoking.

Cigarette smoke, for example, has been found to enhance

vasoconstriction, increase the incidence of oxidized lipid, and generate thrombin
formation, all of which have been shown to contribute to the development of vascular
disease (Kimura et al, 1994).

Each stage of lesion formation is reversible should

the damaging factors be removed and protective factors intervene to inhibit the
fibroproliferative and inflammatory processes.
Polycyclic Aromatic Hydrocarbons
Polycyclic aromatic hydrocarbons (PAHs) are environmental contaminants
present in tar, coal, soot, and other fossil fuels, although they are also found in
charred foods and cigarette smoke where many individuals may encounter them.
Although these contaminants are relatively inert in their original form,
biotransformation in humans and many animal species renders them potent
carcinogens and putative atherogens (Parkinson, 1996).

Benzo(a)pyrene (BaP)

and dimethylbenzanthracene (DMBA) are two of the most toxic and well studied PAHs
and will therefore be used in describing the nature of PAH metabolism and toxicity.
PAH Metabolism
PAHs are structurally related by an anthracene backbone (Figure 5).

The

degree of toxicity of each PAH depends upon the modifications to the anthracene ring;
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DMBA is the most potent of the PAHs (Pitot and Dragan, 1996).

Although these

compounds are chemically inert in their original form, they are capable of
accumulating within cells and perturbing cell function (Pitot and Dragan, 1996).
Once metabolized, BaP and DMBA are immunosuppressants, carcinogens, and putative
atherogens.

ANTHRACENE

Figure 5.

BENZO(A)PYRENE

CH3
7, 12-DIMETHYLBENZANTHRACENE

Chemcial Structures of Anthracene, Benzo(a)pyrene, and 7,12Dimethylbenzanthracene.

PAHs can be metabolized by phase I or phase II metabolism.

Phase I

metabolism occurs on the endoplasmic reticulum via the cytochrome P450 mixed
function oxidase system, ultimately making the compound more polar by introducing
oxygen. Phase II metabolism occurs in the cytoplasm through biosynthetic reactions
involving conjugation by methylation, glucuronidation, sulfation, etc. (Parkinson,
1996).

PAHs (as well as cigarette smoke) induce cytochrome P450-1A1 which

biotransforms and metabolically activates these compounds into toxic epoxides
capable of binding DNA or generating reactive oxygen intermediates. These reactive
epoxides may also be formed during prostaglandin synthesis within the cell
(Parkinson, 1996).

Some epoxides are receptive to epoxide hydrolase, an enzyme

found within the microsomes of most animal tissues; this enzyme detoxifies the
epoxide by adding a water moiety to the epoxide bond (Parkinson, 1996). Phase II
metabolism may detoxify these chemicals by glucuronidation or glutathione reduction
of the epoxide.

14
The process by which PAHs are bioactivated through cytochrome P450
metabolism has been elucidated by Stegeman et al., (1995) and is described below.
PAHs induce transcriptional activation and message stabilization of the CYP1A 1 gene.
Induction of the cyp1A1 protein requires transcriptional activation and derepression
of the cytosolic arylhydrocarbon receptor.

The arylhydrocarbon receptor exists in

the cytoplasm bound to two hsp 90 proteins. Binding of the PAH ligand dissociates
the heat shock proteins from the receptor, allowing the receptor to be
phosphorylated via a tyrosine kinase which activates the receptor.

The active

arylhydrocarbon receptor is then translocated to the nucleus by complexing with an
arylhydrocarbon receptor nuclear translocator (AhRcnt).

Once in the nucleus, this

complex binds the CYP1A 1 regulatory sequence, thereby inducing transcription of
CYP1A 1, such that the cyp1A1 protein will be translated and biotransformation of
the PAH can occur. This metabolism can be carried out by a variety of cell types,
including vascular endothleium (Stegeman et al., 1995).
PAH Toxicity

Once metabolically activated, PAHs are capable of forming DNA adducts and
inducing point mutations, making them potent genotoxins.

Studies indicate that

inhaled cigarette smoke induces more than a twofold increase in lung DNA adducts in
rats (Bond et al., 1989).

Cell proliferation following mutation may fix DNA damage,

or DNA damage may inhibit the cell cycle and induce apoptosis if the arrest is
prolonged (Rogers and Kavlock, 1996).

Unlike many xenobiotics, PAHs exert their

toxicity (once metabolized) at the first site of contact (Pitot and Dragan, 1996),
explaining the high incidence of skin carcinomas induced by these chemicals.
PAHs are also capable of inducing vascular damage which may be related to
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the development of atherosclerosis.

In studies using chickens and pigeons, PAHs

were capable of inducing smooth muscle tumors in the vascular wall when given in
an initiation-promotion sequence (Albert et al., 1977; Bond, et al., 1981; Majesky
et al., 1985; Revis et al., 1984).

The putative role that PAHs may play in the

atherosclerotic process has been attributed primarily to effects on vascular smooth
muscle. These chemicals are capable of deregulating vascular smooth muscle cell
growth through interaction and inactivation of protein kinase C, while enhancing the
transcription of growth related genes by binding to cytosolic receptors that act as
ligand activated transcription factors, and ultimately alter gene expression (Ramos

et al., 1996).

REVIEW OF RELATED LITERATURE
Role of the Endothelium in LDL Uptake
Lipid accumulation in the vessel intima is characteristic of fatty streak
development in the early stages of atherogenesis. Because these lesions occur in the
absence of endothelial denudation, it has been suggested that subtle alterations in
endothelial metabolism or ultrastructure allow the movement of lipids into the
subendothelial space (Alexander et al., 1991; Guretzki, et al., 1994). Lipids in the
circulation are subject to oxidative modification by reactive oxygen intermediates
and by interaction with cellular components of the vessel; lipid may also be oxidized
within the endothelium (Alexander et al., 1991).

Oxidized LDL is capable of

exerting cytotoxic effects on the endothelium (Holland et al., 1992), resulting in
altered permeability such that more lipid is allowed to pass into the subendothelial
space of the vessel. Additionally, Holland and coworkers (1992) have shown that the
.- .
endothelium increases endocytosis of LDL when exposed to elevated
circulating lipid

levels.

Intracellular oxidation of LDL alters endothelial permeability through an

increase in intracellular calcium which induces changes in the cytoskeleton of the
cell (Hamilton et al., 1994).

The increased permeability allows additional lipid to

accumulate in the vessel wall.
cells undergoing turnover.

Enhanced permeability has also been identified in

Weinbaum and Chien (1993) have shown that cells

involved in turnover exhibit temporarily leaky intercellular junctions, also
allowing the possibility of lipid uptake into the subendothelial space.
Increased endothelial permeability has also been attributed to the trapping of
LDL within the subendothelial space. The cytoskeletal changes within the endothelial
16
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cells allow accumulating lipid to contact the basement membrane which consists of
collagen, laminin, and a heparin sulfate proteoglycan (HPSG) (Guretzki, et al.,
1994).

The core protein of HPSG resembles the LDL receptor (Guretzki, et al.,

1994), such that LDL is able to adhere to the basement membrane and thus becomes
trapped as a result of the increase in endothelial permeability to LDL.
Endocytosis of LDL occurs via one of two processes. There is a high affinity,
saturable receptor which is active at LDL concentrations below 50 µg/ml protein,
and there is a low affinity, non-saturable process which is important when LDL
concentrations are elevated (Poumay and Ronveaux-Dupal, 1989).

While the low

affinity process has not been well characterized, the high affinity receptor mediated
process is understood in more detail.

Poumay and Ronveaux-Dupal (1989) have

shown that binding of LDL to specific receptors occurs on the endothelial membrane,
followed by invagination into the cell on coated pits, where the complexes are
identified as endosomes. The LDL is then uncoupled from the receptor so that it may
be recycled and the ligand is transferred to juxtanuclear endosomes where it is
degraded and used for membrane synthesis (Poumay and Ronveaux-Dupal, 1989).
In addition, there are several endothelial receptors which recognize and internalize
LDL depending upon the extent to which it has been oxidized; the B/E LDL receptor
recognizes native or minimally oxidized LDL while the scavenger receptor recognizes
oxidized LDL (Penn and Chisolm, 1994).
Role of the Endothelium in Monocyte Adhesion
Focal monocyte adherence to the endothelium and subsequent migration into
the subendothelial space are observed in the first stages of atherosclerosis.
Monocyte adhesion occurs when endothelial cells become 'activated', such that they
express adhesion molecules as well as stimulators and chemotactic molecules for

1 8

leukocytes.

Endothelial cells may be activated by cytokines, chemical injury,

inflammation, and oxidized LDL. There are three steps involved in the adhesion and
transmigration process: the first stage involves the rolling of monocytes along the
endothelial surface (mediated by selectin molecules), the second involves attachment
to the endothelium (mediated by integrins and immunoglobulin-like molecules), and
the third involves the transmigratory process of the monocytes into the
subendothelium

(Takahashi et al., 1994).

Farqi and DiCorleto (1993) have

identified inhibitors of endothelial-monocyte adhesion which act by inhibiting
cytokine-stimulated expression of endothelial adhesion proteins through the
inhibition of protein kinase C signaling mechanisms.
Selectins
Selectins (also known as LECCAMs) are calcium dependent adhesion molecules
which mediate low strength adhesions (tethering) and rolling of leukocytes to the
endothelium (McEver, 1993).

The selectins belong to a family of glycoproteins

which are not present on unstimulated endothelial cell surfaces, but appear on the
surface of the endothelium after activation (Faruqi and DiCorleto, 1993).

E

selectin (also known as ELAM-1; endothelial-leukocyte adhesion molecule-1) and
P-selectin (also known as PADGEM or GMP-140; platelet activation dependent
granule to external membrane protein or granule membrane protein-140,
respectively) are the two selectins found on activated endothelium (Faruqi and
DiCorleto, 1993).
Endothelial E-selectin expression is stimulated by IL-1 or TNF-a. within 26 hours following stimulation (protein synthesis is necessary for its expression),
while P-selectin is stimulated by histamine or thrombin and can be found both in

1 9

endothelium

and

in platelets within 5-30

(Beekhuizen and van Furth, 1993).

minutes

following stimulation

P-selectin is stored in the Weibel-Palade

bodies of the endothelium (a-granules in platelets) until cellular activation when it
is translocated to the plasma membrane by exocytosis (Beekhuizen and van Furth,
1993).

The selectins recognize carbohydrate ligands on the monocytes which are

identified as sialyl Lewis X (sleX) (Faruqi and DiCorleto, 1993). Monocytes loosely
tethered to endothelial cells by selectins are exposed to activators which are capable
of inducing tight endothelial-monocyte adhesion.
lmmunoglobulin-like Molecules
Members of the immunoglobulin {lg) superfamily are mediators of the
immune response. Some lg-like molecules have been identified which act as adhesion
receptors in cell-cell interactions (Dianzani and Malavasi, 1995).

ICAM-1

(intercellular adhesion molecule-1), ICAM-2, and VCAM-1 (vascular cell adhesion
molecule-1) are lg-like receptors present constitutively at low levels on the
endothelial surface that are involved in endothelial-monocyte adhesion (Beekhuizen
and van Furth, 1993).

These receptors are upregulated within 12-48 hours

following endothelial activation and bind with specific ligands on various leukoctyes
(Beekhuizen and van Furth, 1993).
lntegrins
lntegrins are adhesion molecules which play critical roles in immune
function, platelet aggregation, and wound healing (Dianzani and Malavasi, 1995).
Certain specific integrins on monocyte cell surfaces mediate endothelial cell adhesion
by binding to lg-like counterreceptors (discussed previously) on the endothelial
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surface (McEver, 1993).

Activation of tethered monocytes results in rapid

increases in the avidity of the integrin-counterreceptor interaction, although the
mechanism behind this process remains to be elucidated (McEver, 1993).

The

integrin LFA-1 (lymphocyte function related antigen-1) is the counterreceptor to
ICAM-1

and ICAM-2, and the integrin VLA-4

(very late antigen-4) is the

counterreceptor to VCAM-1 (Faruqi and DiCorleto, 1993).

LFA-1 is found on

lymphocytes, monocytes, and polymorphonuclear cells, while VLA-4 is present on
lymphocytes, monocytes, and eosinophils, but not on neutrophils (Faruqi and
DiCorleto, 1993).

lntegrins have also been found to interact with cytoskeletal and

extracellular matrix components, making them important in the transmigratory
process of monocytes into the subendothelium.
Role of the Endothelium in Monolayer Permeability
The integrity of the endothelial monolayer is critical in regulating the
passage of plasma proteins and blood components between the circulation and the
vessel wall.

Alterations in monolayer permeability, especially to lipoproteins, have

been found to be important to cardiovascular disease processes. Permeability across
the endothelial monolayer is thought to be regulated by two pathways: a transcellular
path via vescicle transcytosis and junctional transport via dynamic opening and
closing of the intercellular junctions (Caveda et al., 1995; Chen et al, 1995;
Schnittler et al., 1990). The transcytotic pathway shuttles macromolecules between
the luminal and abluminal surfaces (Schnittler et al., 1990), while the junctional
pathway carries smaller molecules through a pore system; larger molecules such as
LDL are able to cross via the junctional pathway of mitotic or dying cells where the
junctions are leaky (Chen et al, 1995).
Platelets, plasma proteins, norepinephrine, and the vasodilator prostacyclin
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{which is produced in response to bradykinin and thrombin) have been found to
reduce vascular permeability (McDonagh, 1986; Casnocha et al., 1989; Siflinger
Birnboim et al., 1988).

On the other hand, bradykinin, histamine, and thrombin

have been found to increase permeability (Casnocha et al., 1989; Siflinger
Birnboim et al., 1988).

Several studies suggest that these effects are mediated

through cytoskeletal alterations, which induce changes in endothelial cell shape.

In

cases of acute inflammation, large gaps in the intercellular junctions are produced
by contractile mechanisms of the cytoskeleton (Shasby et al., 1985; Schnittler e t
al., 1990).

Schnittler and coworkers (1990) have discovered that endothelial cells

contain actin and myosin which allow ATP-dependent contraction and shortening of
the cell.
The increase in permeability is a result of gap formation within the
intercellular junctions, thus enhancing paracellular transport.

Gap formation is

induced as a result of cytoskeletal changes. Schnittler et al. {1990) has suggested
that this change in the contractile state of the cytoskeleton is due to increased
intracellular calcium.

The phospholipase C-mediated increase in calcium results in

the formation of calcium-calmodulin complexes which activate the myosin light
chain kinase (MCLK) (Schnittler et al., 1990). MCLK becomes phosphorylated and
induces contraction through myosin and actin interactions.

In contrast, permeability

is decreased by inducing relaxation. This is accomplished by increasing cAMP levels
through the induction of specific G proteins and adenylate cyclase, although the
precise mechanism has yet to be elucidated (Schnittler et al., 1990).
Objectives of the Study
Polycyclic aromatic hydrocarbons have been shown to initiate and to promote
atherosclerosis and carcinogenesis in quail, chicken, and rabbit species (Ou and
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Ramos, 1992; Majesky et al., 1985; Bond et al., 1981; Albert et al., 1977). This
has been demonstrated primarily by the increase in incidence and in size of vascular
smooth muscle cell tumors in these animals when exposed to benzo(a)pyrene or
dimethylbenzanthracene. The endothelium has also been identified as an important
mediator in vascular disease and in the atherogenic process, although the endothelial
effects induced by these chemicals have not been investigated. Therefore, the first
objective of this study was to elucidate the concentrations at which benzo(a)pyrene
or dimethylbenzanthracene might induce an endothelial response without causing
overt cytotoxicity.

Secondly, our objective was to assess the toxicity of these

chemicals at these relevant concentrations, and thirdly, to determine what functional
changes (changes in monolayer permeability, monocyte adherence, and LDL uptake)
benzo(a)pyrene and dimethylbenzanthracene might induce in the endothelium which
could contribute to the atherogenic process.
Significance of the Study
Atherosclerosis is now considered a leading cause of death in the United
States, as it is an underlying component in most cases of cardiovascular disease.
Elevated cholesterol levels, hypertension, and cigarette smoke are known risk
factors which have been strongly correlated with the development and enhancement
of atherosclerosis in humans.

However, it has yet to be determined which of the

greater than 4,000 chemicals in cigarette smoke may be responsible for atherogenic
effects. Atherosclerotic lesions have been described as benign smooth muscle cell
tumors within the vessel wall (Benditt and Benditt, 1973).

Thus, a number of

studies have been conducted to assess the ability of the carcinogenic polycyclic
aromatic hydrocarbons found in cigarette smoke to induce and enhance the
development and progression of atherosclerosis in various species.

Investigators have now shown the endothelium to be an important mediator in
the onset and progression of the atherogenic process, although the effects of these
hydrocarbons on the endothelium have not been determined.

Elucidation of the

general toxicity and of the functional changes induced in endothelium by these PAHs
may further contribute to our understanding of the process by which cigarette smoke
induces vascular damage.
Developing a preliminary profile of the effects of benzo(a)pyrene and
dimethylbenzanthracene in cultured endothelium is inexpensive, yet provides a
descriptive assessment of PAH-induced endothelial injury.

The porcine aortic

endothelium used in this study was chosen because of the tendency of this species to
spontaneously develop atheromas similar in composition and in location to those
found in the human aorta (McCauley and Bull, 1980).

In addition, porcine aortic

endothelial cells contain arylhydrocarbon hydroxylase (AHH), the cytochrome P450
1 A 1-dependent enzyme necessary for bioactivation of PAH's (Manchester, et al.,
1984; Parkinson, 1996).
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MATERIALS AND METHODS
Cell Culture and Chemical Administration
Cell Culture
Porcine aortic endothelial cells (PECs) were isolated according to a modified
method of Reindel et al. (1991 ).

Sections of aorta (approximately 1.5 inches in

length) were aseptically removed from freshly slaughtered hogs (obtained from
Pease Meat Packing Co.), rinsed in sterile Hank's balanced salt solution (HBSS)
(Sigma Chemical Company, St. Louis, MO) containing 3% antibiotic/antimycotic
(Ab/Am) (300 U/ml penicillin, 300 µg/ml streptomycin, 0.75 µg/ml Fungizone;
Gibco, Grand Island, NY), and then placed into fresh HBSS containing 3% Ab/Am on
ice for transport to the laboratory. In a laminar flow hood, the aortic sections were
prepared for cell isolation with careful dissection of adipose and connective tissue
from the surrounding adventitia. A section of artery was then cut longitudinally, and
placed lumen side down into a 100mm tissue culture plate containing a thin film of
collagenase (Type 1A, 0.1%; Sigma).

After 2-4 minutes in the collagenase, the

vessel was carefully removed and the luminal side lightly scraped with a single
brush of a sterile rubber policeman.

The cells on the policeman were gently

resuspended in a clean 100mm tissue culture plate containing HBSS.

Using a

micropipette, small groups of the resuspended cells were collected into 12-well
tissue culture plates (Becton Dickinson, Lincoln Park, NJ) containing 0.5 ml Opti
Mem (Gibco) with 1 % Ab/Am and 5% fetal bovine serum (FBS) (lntergen,
Purchase, NY) under an inverted phase microscope (BioStar; Leica, Inc. (American
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Optical), DePew, NY).
Cells were incubated for 14 days at 37 °C with 5% CO2 /95% air, with fresh
media given on day 7.

On day 14, colonies of endothelial cells with cobblestone

morphology, free of spindle cells resembling fibroblasts and/or smooth muscle,
were passed into 6-well tissue culture plates with 0.25% trypsin/0.01 M EDTA
(Gibco) and allowed to reach confluence, with fresh media given every other day.
After the 3rd passage, cells were plated and maintained in 100mm tissue culture
plates containing 10 ml Opti-Mem with 1% Ab/Am and 3%FBS. Cells were passed at
a 1 :3 ratio every 5-7 days, and only cells between passages 4 and 10 were used for
experimental procedures.
Chemical Preparation and Administration
B enzo( a)pyrene

( BaP)

(3,4-benzpyrene;

Sigma)

and

7, 12-

dimethylbenzanthracene (DMBA) (9, 1 0-dimethyl-1,2-benzanthracene; Sigma)
were dissolved in dimethylsulfoxide (DMSO) (Sigma) at a stock concentration of 25
mg/ml, and stored at 4 °C.

The stocks were serially diluted in DMSO such that

administration of 5 µI of chemical to wells containing 2 ml of Opti-Mem or of 25 µI
of chemical to plates containing 10 ml of Opti-Mem resulted in concentrations of
0.001, 0.01, 0.1, 1, or 10 µM BaP or DMBA. Administration of an equal volume of
DMSO vehicle was used to treat control wells.
General Toxicity Assays
Morphology
Endothelial cells (ECs) were plated in 12-well tissue culture plates, allowed
to reach confluence, and treated with 0.01, 0.1, or 1 µM BaP, DMBA, or vehicle.
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Fresh medium containing the chemical of interest was administered every other day,
providing continuous exposure throughout the experimental period. Cells were then
examined microscopically for visible changes in morphology throughout the 240
hour experimental period.

Examinations were performed at 0, 6, 12, 24, 48, 96,

168, and 240 hours. After two days of treatment, various wells were scraped with a
single stroke of a rubber policeman to remove cells in one area of the well. These
wells were then monitored throughout the remainder of the experimental period for
the ability of the remaining cells (treated and controls) to migrate and divide so as to
cover the scraped area of the well. Phase contrast photographs were then taken of
live cultures and of cultures fixed with 10% formalin in HBSS and stained with
0.5% crystal violet (Sigma).

The viability of detached cells in the wells was

determined by trypan blue exclusion (Sigma).
Cell Number
Cells were plated and treated as described above. At each timepoint, triplicate
wells from each treatment group were rinsed twice with calcium free HBSS, then
adherent cells were removed by the addition of 1 ml trypsin/EDTA and diluted in 9
ml of isotonic diluent (USA Scientific; Ocala, FL).

Cells were quantitated using a

Coulter Counter (Model F; Coulter Electronics, Luton, England); each well was
counted three times.
Protein Content
Cells were plated and treated as described above. At each timepoint, cells
were washed twice with HBSS and then lysed in 1 ml of 0.1 M NaOH. Cellular protein
content was determined by a modification of the Bradford method (1976), using
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Bovine serum albumin (Bio-Rad laboratories, Cambridge, MA) as a standard.
Samples were analyzed in duplicate at 595nm using a microplate reader
spectrophotometer (Model 450; Bio-Rad Laboratories). Results are expressed as
mean protein content per cell.
Lactate Dehydrogenase Release
Release of lactate dehydrogenase (LOH) activity into the medium by ECs was
determined by modification of the method of Bergmeyer and Bernt (1974). Medium
was removed from triplicate wells in each treatment group for analysis, and each
sample was analyzed in duplicate. Cell monolayers were then rinsed twice in HBSS,
and lysed in 2 ml of 10% triton X-100 in HBSS.
centrifuged and

Lysate was sonicated and

the supernatant was analyzed for LOH activity.

Results are

expressed as the percent of total LOH released into the medium.
Cell Proliferation/ DNA Synthesis
Cells were plated as described above. At confluence, EC monolayers were
growth arrested for 72 hours in M199 medium (Gibco) containing 1% Ab/Am and
0.2% bovine serum albumin (BSA) (Sigma).
Opti-Mem containing 1% Ab/Am and
DMBA as described above.

3%

At 72 hours, cells were given fresh

FBS and were treated with either BaP or

At each timepoint, thymidine incorporation was

determined according to the method of Hoorn and Roth (1992). Cells were pulse
labeled with 2 µCi/ml of 5-methyl-3 H thymidine

(40-60 Ci/mmole;

ICN;

Cleveland, OH) for 2 hours under the incubation conditions described above. Cells
were then placed on ice for
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minutes and washed three times in cold phosphate

buffered saline (PBS) to remove unincorporated tracer.

0.5 ml of ice cold 10%

trichloroacetic acid (TCA) was added to cells on ice, and after 1O minutes, wells
were washed with 75% ethanol, and then with 95% ethanol. 0.5 ml of 1 N NaOH was
added to each well, and wells were incubated overnight. Finally, 0.5 ml of 1 N HCI
was added to each well, and 75 µI aliquots were added to 1O ml of liquid scintillant;
each well was analyzed in duplicate.

Radioactivity was determined in a liquid

scintillation counter, and results reported as disintegration's per minute (dpm) per
cell.
Colony Formation
Cells were plated into 100 mm tissue culture plates at a density of 1000
cells/plate and given 2 hours to adhere.

At this time, plates were treated with

vehicle, 0.001, 0.01, 0.1, 1, or 10 µM BaP or DMBA and were then incubated for 1
week. (Each treatment group for each chemical consisted of 6 plates). After 1 week,
fresh medium was given to all plates, but only three of the six plates in each
treatment group were retreated with BaP or DMBA. Plates were incubated for one
more week, after which cells were fixed with 10% formalin in HBSS and stained
with 0.5% crystal violet. Colonies consisting of greater than 50 cells were counted,
and results were expressed as a percent of control.

Results from plates given a

single administration of chemical are reported separately from those which were
retreated.
Functional Studies
Low-density Lipoprotein (LDL) Uptake
Cells were plated in 8-well tissue culture plates (Becton-Dickinson) on
sterile glass coverslips (Sigma), and treated as described above.

At each timepoint,
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fresh Opti-Mem containing 1% Ab/Am, 3% FBS, and 10 mg/ml acetylated low
density

lipoprotein

labeled

with

1, 1'- d i o c ta d e c y l-3,3,3' ,3'

tetramethylindocarbocyanine perchlorate (Dil-Ac-LDL) (Biomedical Technologies,
Inc.; Stoughton, MA) was added for 4 hours of incubation. Medium was then removed
and cells were washed twice in unlabeled Opti-Mem, and twice in HBSS. Coverslips
were gently removed from the wells and placed into 3% formaldehyde in PBS for 20
minutes at room temperature. Coverslips were then rinsed for 5 seconds in distilled
water, allowed to dry, and inverted on a microscope slide (Sigma) with a drop of
90 % glycerol in PBS.

LDL uptake was then quantified using the image analysis

system, Image 1 (Universal Imaging Corp., West Chester, PA) with standard
rhodamine excitation: emission filters.

Cell number was determined visually under

the microscope for each field. A minimum of 10 fields at 400X magnification were
examined for each treatment group and results expressed as fluorescence intensity
per cell.
Monolayer Permeability
Endothelial monolayer permeability to albumin was determined according to
modified methods of Allen and Coleman (19 95) and Gudgeon and Martin (1989).
Cells were plated into 24-well plates (Becton-Dickinson) containing 0.4 µ cell
culture inserts (Becton Dickinson) according to manufacturer's instructions.

Cells

were incubated for 5 days to ensure confluence, and then treated with either vehicle
or 1µM BaP or DMBA. (Media and chemical were always placed both in the luminal
chamber of the insert and in the abluminal chamber, or well, of the plate). Media
changes were performed according to the instructions given with the cell culture
inserts.

At each timepoint, treated inserts were rinsed carefully with Krebs-
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Heinslet buffer (Sigma) and placed into a fresh 24-well tissue culture plate
containing 600 µI of Kreb's buffer.

100 µI of 40g/L albumin/trypan blue complex

(albumin and trypan blue: Sigma) was added to the luminal chamber of each insert
and incubated for 1 hour under standard incubation conditions.

200 µI from each

abluminal chamber was then extracted (in duplicate) without removing the insert so
that the permeability of the monolayer to the albumin/trypan complex could be
assessed.

Samples were analyzed using a microplate reader spectrophotometer

(Model 450; Bio-Rad Laboratories) at 5 95 nm.

Standards were prepared using a

g/L solution of the albumin-trypan blue complex.

5

Results are expressed as a

percent of equilibrium concentration, where 100% equilibrium concentration is
equal to : (concentration of albumin/trypan complex; 40 g/L)(amount of complex
added to luminal chamber; 100 µI)/(total volume; 700 µI)=

5.714

g/L.

Monocyte Adherence
Monocyte adherence to EC monolayers was determined by a modification of
methods from Clerck et al. (1994) and Akeson and Woods (1993). Cells were plated
in 24-well tissue culture plates and treated as described above.

THP-1 cells,

(ATCC; Rockville, MD) a human acute monocytic leukemia cell line, were maintained
in standard incubation conditions with RPMI 1640 (Gibco) containing 1% Ab/Am,
10% FBS, and

5

x 10- 5 M 2-mercaptoethanol.

Before monocyte labeling, THP-1's

were washed in HBSS and concentrated to 1 x105 cells/ml.

Aliquots of 1x105

cells/ml were centrifuged at 400 x g for 10 minutes at room temperature and
resuspended in 1 ml of

5

µM calcein-AM in HBSS (Molecular Probes; Eugene, OR),

then incubated for 15 minutes under standard conditions. Labeling was stopped by
washing twice with HBSS and centrifugation.

For the adhesion assay, ECs were
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washed twice with HBSS, and Calcein-AM labeled THP-1 's (1 x105 cells/ml) were
added to each well and co-incubated for 30 minutes under standard conditions.
Following incubation, each well was carefully washed 3 times with PBS to remove
non-adherent monocytes, followed by inversion of the plate and blotting of excess
liquid on to absorbent paper. ECs and adherent THP-1's were maintained in PBS for
microscopic examination. Adherent THP-1's were counted visually using standard
fluorescein excitation: emission filters.

One well of endothelial cells from each

treatment group was used for cell number determination (procedure described in
materials and methods under cell number). Results are expressed as a ratio of the
total number of adherent monocytes (THP-1 's) to EC number± SEM.
Statistical Analysis
Data are reported as means ± SEM. [Alternatively the SED for the data set
may be reported]. Data were analyzed using a random analysis of variance, and
individual comparisons were made with Tukey's HSD test. Percentage data was
transformed prior to statistical analysis using
significance was p<0.05.

✓arcsin .

The criterion for

RESULTS
General Toxicity Assays
Morphology
Confluent monolayers treated with 0.01, 0.1, or 1 µM BaP or DMBA or with
an equal volume of DMSO vehicle were examined throughout the 240 hour
experimental period for visible changes in morphology.

At 48 hours post

treatment, vacuolization of cells treated with either 0.1 or 1 µM BaP or DMBA was
evident, and the monolayers became increasingly vacuolated at 96 hours, 168 hours,
and 240 hours.

Very little vacuolization was seen in vehicle and 0.01 µM BaP or

DMBA treated cells throughout the 240 hour period.

Cells treated with vehicle or

0.01 µM BaP or DMBA retained typical cobblestone morphology throughout the 240
hour experimental period, while cells treated with 0.1 or 1 µM BaP or DMBA were
enlarged (in comparison to vehicle treated controls) and demonstrated an elongated,
spindle-like morphology at 168 and 240 hours post-treatment (Figure 6).
Increased cell detachment was also observed in the 0.1 and 1 µM BaP or DMBA
treated monolayers at 168 and 240 hours post-treatment. Results from trypan blue
exclusion indicated that the detached cells were viable.
In a separate experiment, the endothelial monolayer of both vehicle and 1 µM
DMBA or BaP treated wells was partially removed with a single stroke of a rubber
policeman at 2 days post-treatment.

Cells were then examined throughout the

remainder of the experimental period for their ability to migrate and divide so as to
cover the scraped area of the well. Cells treated with vehicle were found to migrate
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into the scraped area and divide; individual cells along the scraped region appeared to
be elongated or stretching, so as to reach into the scraped area of the well. Cells
treated with DMBA or BaP did not show the same extent of migration or division;
individual cells along the scraped region became enlarged and rounded in appearance
and were not elongating or stretching into the scraped area of the well.

Figure 6.

Treatment-Induced Morphological Changes in Cultured Porcine Aortic
Endothelium. Cells were treated with DMSO vehicle (left) or 1 µM
DMBA (right). Photographs were taken at 7 days post-treatment, 40 x
magnification. Cells stained with 0.5% crystal violet.

Cell Number
The effect of continuous exposure to either BaP or DMBA on endothelial cell
number was determined as described in Materials and Methods.

Control PECs

continued to divide and increase in number throughout the experimental period
(Figures 7 and 8).

Cells treated with 0.01 µM BaP or DMBA also increased in

number throughout the experimental period.

Monolayers treated with 0.1 µM BaP

or DMBA showed increasing cellularity with time, although the cell number at 240
hours was significantly less in comparison to 240 hour controls for both BaP- and
DMBA-treated monolayers. Cells treated with 1 µM BaP or DMBA showed only a
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very slight increase in number with time.

The number of cells in monolayers

treated with 1 µM BaP or DMBA was significantly lower than controls at both 168
and 240 hours. While the cellularity of monolayers treated with 0.1 or 1 µM BaP
or DMBA did not increase, monolayer cellularity at any point during the experiment
was not lower than the cell number at the onset of the experiment.
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Protein Content
The effect of continuous exposure to either BaP or DMBA on endothelial cell
protein content was determined as described in Materials and Methods. Total protein
per well increased throughout the experimental period in cells treated with either
BaP or DMBA. Wells treated with 0.1 µM or 1 µM BaP or DMBA showed a modest
increase in total protein content in comparison to controls and 0.01 µM BaP- or
DMBA-treated cells (data not shown).

Figures 9 and 10 show changes in cellular
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protein content for monolayers treated with BaP or DMBA, respectively.

PEC

monolayers treated with BaP showed no significant differences in cellular protein
from vehicle controls at any time during the experimental period.

Cellular protein

decreased from 3.6 ng protein per cell to 2.1 ng protein per cell during the first 48
hours of the experiment, after which levels began to increase in all treatment
groups. At 168 hours, cellular protein content had increased to 3.5-3.8 ng protein
per cell, approximately equal to zero hour levels.

At 240 hours, cellular protein

had decreased to levels between 1.4 and 1.7 ng per cell, less than 50% of zero hour
measurements.
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PEC monolayers treated with DMBA followed trends in protein content
similar to BaP treated monolayers. Cellular protein decreased from 3.7 ng protein
per cell to less than 2 ng protein per cell during the first 24 hours of the
experiment in all treatment groups, after which levels increased (to approximately
3.4 ng protein per cell) in vehicle, 0.1, and 1 µM DMBA-treated cells.

However,

treated with 0.01 µM DMBA showed a significant decrease in cellular protein content
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at 24 hours to less than 1ng protein per cell. At 48 hours, cellular protein content
for all treatment groups was approximately 2.4 ng protein per cell.

Cellular

protein content increased in all treatment groups through 168 hours, at which time
1 µM DMBA treated monolayers had a significantly increased cellular protein content
in comparison to vehicle treated controls.

At 240 hours, cellular protein had

decreased in all treatment groups, although 1 µM DMBA treated monolayers had a
significantly increased cellular protein content in comparison to vehicle treated
controls.
LOH Release
LOH release from treated monolayers was monitored in the culture medium as
described in Materials and Methods as a measure of chemical-induced cytotoxicity.
Significant LOH release was not evident in any of the BaP or DMBA treatment groups
throughout the experimental period (data not shown).
DNA Synthesis
The effect of continuous exposure to either BaP or DMBA on endothelial cell
DNA synthesis as indicated by incorporation of 3H thymidine was determined as
described in Materials and Methods. Figures 11 and 12 show cellular changes in DNA
synthesis for monolayers treated with BaP or DMBA, respectively.

Monolayers

treated with BaP showed an increase in dpm per cell throughout the first 48 hours of
the experimental period. Cells treated with 0.01 µM BaP showed a significant
increase in thymidine incorporation at 24 hours (0.3376 dpm per cell) and 48
hours (0.4099 dpm per cell) in comparison to vehicle treated controls (0. 24 71 and
0.2769 dpm per cell), while monolayers treated with 1 µM BaP showed decreased
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thymidine incorporation in comparison to vehicle treated controls at 24

hours

(0.1408 dpm per cell) and 48 hours (0.2286 dpm per cell)(significant at 24
hours).

By 96 hours, thymidine incorporation had returned to zero hour levels in

all treatment groups, and showed little change at 168 hours. At 240 hours, dpm per
cell was slightly lower than zero hour levels (0.1547 dpm per cell) for all
treatment groups, with 1 µM BaP treated cells the lowest at 0.0389 dpm per cell.
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PEC monolayers treated with

DMBA followed trends in thymidine

incorporation similar to BaP treated monolayers.

Monolayers treated with DMBA

showed a decrease in thymidine incorporation throughout the first 12 hours of the
experimental period, followed by an increase through 48 hours, evident in all
treatment groups. At 48 hours, cells treated with 0.01, 0.1, or 1 µM DMBA showed
an increase in thymidine incorporation in comparison to vehicle treated controls; the
increase in 0.01 µM DMBA-treated cells (0.3555 dpm per cell) was significantly
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greater than controls (0.261 dpm per cell).

At 96 hours, thymidine incorporation

had decreased in all treatment groups; levels in 0.01 and 0.1 µM DMBA-treated cells
were significantly greater than vehicle treated controls.

At 168 hours thymidine

incorporation in vehicle, 0.1, and 1 µM BaP treated cells remained similar to 96
hour measurements, while 0.01 µM BaP treated cells showed a further decrease in
thymidine incorporation. At 240 hours, dpm per cell had continued to decrease in all
treatment groups.
Colony Formation
Cells were plated at low density and treated with either a single
administration or a double administration of chemical as described in Materials and
Methods. At the end of the experimental period, colonies consisting of at least 50
cells were counted and results reported as a percent of vehicle-treated controls.
Results indicate that colony forming ability decreases with increasing concentration
of BaP or DMBA (Figure 13).

Cells treated with 0.001, 0.01, 0.1, 1, and 10 µM

BaP were significantly inhibited in their ability to form colonies in comparison to
controls.

BaP reduced colony formation to 76%, 68%, 49%, 23%, and 16% of

controls at concentrations of 0.001, 0.01, 0.1, 1, and 10 µM BaP, respectively.
Cells treated with 0.01, 0.1, 1, and 10 µM DMBA were significantly inhibited in
their ability to form colonies in comparison to controls.

DMBA reduced colony

formation to 90%, 65%, 44%, and 34% of controls at concentrations of 0.001,
0.01, 0.1, 1, and 10 µM DMBA, respectively.

Colony formation in plates given a

single administration of BaP or DMBA at time zero did not differ significantly from
colony formation in plates which were given a second administration of chemical at 7
days post-treatment (data not shown).

42

--.

-

I-•-

*

10 0

0

---0--

C

0

0

80

w

60

�
0

BaP Treated Cells
DMBA Treated Cells

tJ)

C

E
._

0
LL

40

>,.

C

0
0

*

20

0
0

,,
-------------....----...-------,.------+-',,
'
0

0.001

0.01

0.1

Treatment

10

(uM)

Figure 13. Colony Forming Efficiency of Cells Treated With BaP or DMBA. Graphed
data represents cells treated with a single administration of chemical.
'*' denotes significance from controls. Values represent means of
replicate studies (n=3, BaP; n=4, DMBA). [100% represents 456
colonies per plate for BaP treated cells and 119 colonies per plate for
DMBA treated cells).
Microscopic examination of colonies indicated that significant reductions in
colony formation due to chemical treatment were not a result of cell death; individual
EC cells remained adherent in the plates, although they did not divide to form
colonies. These individual cells were enlarged and irregular in appearance. Colonies
existing in plates treated with 1 or 10 µM BaP or DMBA consisted of fewer cells than
colonies in plates treated with vehicle or 0.001 µM chemical.
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Functional Studies
Low-density Lipoprotein Uptake
The effect of continuous exposure to either BaP or DMBA on endothelial cell
LDL uptake was determined as described in Materials and Methods. Figures 14 and
15 show cellular changes in LDL uptake for monolayers treated with BaP or DMBA,
respectively.

Results from BaP experiments showed that there were no significant

changes in LDL uptake of vehicle-treated cells over time. At 24 hours, 0.01 and 0.1
µM BaP treated cells showed an intensity per cell which was slightly less than
vehicle treated controls, while 1 µM BaP-treated cells showed a slight increase. At
48 hours, 0.01, 0.1, and 1 µM BaP-treated cells showed a decreased intensity per
cell in comparison to vehicle-treated controls; all treatment groups at 48 hours
showed an increased intensity per cell in comparison to zero hour controls. At 96
hours 0.1 and 1 µM BaP treated cells showed an increased intensity per cell in
comparison to vehicle controls and 0.01 µM BaP treated cells.

At 168 hours all

treatment groups showed elevated intensity per cell in comparison to vehicle treated
controls, but only 1 µM BaP-treated cells showed a significant increase over
controls.
Results from DMBA experiments showed that there were not significant
changes in LDL uptake of vehicle-treated cells over time, except at 168 hours. At
24 hours all treatment groups from cells treated with DMBA showed an increase in
the intensity per cell in comparison to vehicle treated controls.

At 48 hours all

DMBA treatment groups showed an increased intensity per cell in comparison to
vehicle treated controls; cell intensity was significantly increased in 1 µM DMBA
treated cells.

At 96 hours 0.01, 0.1 and 1 µM DMBA treated cells showed a
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significant increase in the intensity per cell in comparison to vehicle controls.

At

168 hours 0.01 and 0.1 µM DMBA treated cells showed an increase in cell intensity
in comparison to vehicle controls, while 1 µM DMBA treated cells showed a decrease
in cell intensity.
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Monolayer Permeability
The effect of continuous exposure to either BaP or DMBA on endothelial
monolayer permeability was determined as described in Materials and Methods.
Control PECs showed a slight decrease in permeability at 24 and 48 hours, followed
by an increase in permeability at 96 hours and 168 hours at which time the percent
equilibrium returned to the level measured at the onset of the experiment (Figures
16 and 17).

Cells treated with 1 µM BaP (Figure 16) showed a decrease in

permeability at 24 and 48 hours, similar to the decrease in controls. At 96 hours,
the permeability of 1 µM BaP treated cells appeared to increase in comparison to
controls, while the permeability at 168 hours decreased to the level of controls.
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Cells treated with 1 µM DMBA (Figure 17) showed a decrease in
permeability at 24 hours, similar to the decrease in controls.

Permeability to
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albumin at 48 hours following DMBA treatment appears to increase, although the
large variability in results suggests that these values are not different from
controls.

At 96 hours and 168 hours, the permeability of 1 µM DMBA-treated

monolayers to albumin did not appear to change in comparison to controls.
Preliminary results suggest that the permeability of PEC monolayers to albumin is
not affected by treatment with either BaP or DMBA.
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Monocyte Adherence
The effect of continuous exposure to either BaP or DMBA on monocyte
adherence to endothelial cells was determined as described in Materials and Methods.
Figures 18 and 19 show changes in monocyte adherence for monolayers treated with
BaP or DMBA, respectively. Results from BaP experiments showed that there was an
increase in monocyte adherence to vehicle-treated endothelial cells over time. BaP

treated cells show little change in monocyte adherence in any of the treatment groups
in comparison to vehicle controls at 0 and 24 hours.

At 48 hours, monocyte

adherence in 0.01 and 0.1 µM BaP treated cells is increased in comparison to 48
hour controls; 1 µM BaP treated cells show a decrease in adherence in comparison to
controls. At 96 hours monocyte adherence is decreased in all BaP treatment groups
in comparison to vehicle controls. At 168 hours, monocyte adherence is elevated in
all BaP treatment groups, with the greatest adherence in the 0.01 µM BaP treated
cells.
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Changes in monocyte adherence to ECs with DMBA treatment are similar to
the changes which occur in BaP treated cells.

Results from DMBA experiments

showed that there was an increase in monocyte adherence to vehicle-treated
endothelial cells at 168 hours. At 0 and 24 hours there is little change in monocyte
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adherence to ECs in any of the DMBA treatment groups.

At 48 hours all DMBA

treatment groups show an increase in monocyte adherence in comparison to vehicle
controls; the greatest increase in adherence is evident in 0.1 µM DMBA treated cells.
At 96 hours monocyte adherence is increased in all DMBA treatment groups, with the
greatest increase in the 1 µM DMBA treated cells. At 168 hours monocyte adherence
is increased in 0.01 and 0.1 µM DMBA treated cells, but is decreased in 1 µM DMBA
treated cells in comparison to vehicle controls.
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DISCUSSION
Polycyclic aromatic hydrocarbons (PAHs) have been shown to initiate and to
promote atherosclerosis and carcinogenesis in various animal species (Ou and
Ramos, 1992; Majesky et al., 1985; Bond et al., 1981; Albert et al., 1977). These
findings have been demonstrated primarily by the increase in incidence and in size of
smooth muscle cell tumors in these animals when exposed to BaP and DMBA, two of
the most potent PAHs. The endothelium has been identified as a critical regulatory
component of vascular homeostasis, as well as an important mediator in vascular
dysfunction and disease (Nachman and Hajjar, 1991; Fajardo, 1989; Gimbrone et
al., 1995; van Hinsberg, 1992).

However, the endothelial effects induced by BaP

and DMBA have not been studied. Therefore, the first objective of this study was to
elucidate the concentrations and the course of time for which BaP and DMBA induce
an endothelial response without an acute cytotoxic effect.

Secondly, our objective

was to assess the toxicity of these chemicals at relevant concentrations, which may
contribute to chronic vascular disease as a result of prolonged PAH exposure.
Thirdly, we set out to determine what functional changes BaP and DMBA might induce
in the endothelium which are indicative of proatherogenic changes.
The effect of BaP and DMBA on EC morphology was examined throughout the
experimental period.

There was an increased incidence of vacuolization and cell

detachment with time and increasing concentration of chemical treatment, in addition
to cell enlargement and shape change. Figure 6 depicts these changes in 1 µM DMBA
treated cells in comparison to vehicle controls at 168 hours, suggesting that these
PAHs are capable of inducing an endothelial response. The inability of ECs to migrate
and spread into an area void of cells with increasing time and concentration of
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chemical treatment additionally supports the hypothesis that prolonged PAH
exposure at low concentrations induces endothelial injury.

Coomber and Gottlieb

(1990) suggested that cell migration plays a role in the propagation of endothelial
cell replication following injury.

Therefore, if PAHs are capable of inhibiting EC

migration, they may also be capable of inhibiting the proliferative response to
monolayer injury.

Previous studies (Fyfe et al., 1995; Coomber and Gottlieb,

1990) have shown that the proliferative response to endothelial monolayer injury
is critical for preventing the development of vascular disease.
The hypothesis that BaP and DMBA affect EC proliferation was further
investigated by evaluating changes in cell number throughout the experimental
period.

Results from replicate cell number studies show that cell number is

significantly reduced in comparison to controls (Figures 7 and 8) at 168 hours
when treated with 0.1 µM BaP or DMBA and at 168 and 240 hours when treated with
1 µM BaP or DMBA. The results also suggest a direct dose/response relationship
with regard to PAH treatment and cell division; with increasing concentration of
chemical treatment the smaller the cell number in comparison to vehicle controls
(it is important to note that while treated monolayers did not increase in cell
number to the same extent as controls, numbers did not decrease i.e., there was no
overt cell death as a result of chemical treatment). These proliferative responses to
PAH treatment become more pronounced with time, suggesting that prolonged
exposure to BaP or DMBA produces substantial effects. The repair process following
endothelial cell injury includes cell migration, spreading, and proliferation
(Coomber and Gottlieb, 1990). The alteration of these cellular processes as a result
of PAH treatment suggests an inability to repair injury which may result in
prolonged endothelial dysfunction. This may profoundly affect the onset of vascular
disease initiated by other risk factors, or may itself be a key factor in initiating
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vascular dysfunction.

Although atherosclerosis is typically associated with an

increase in both EC and SMC proliferation, Fyfe et al. (1995) have shown that the
immunosuppressant cyclosporin A inhibits both EC and SMC replication (much like
BaP and DMBA) in vitro but is associated with an increase in atherosclerosis in
mice.
The reported changes in cell number following BaP or DMBA treatment could
be attributed to cell death or to a decrease in cell proliferation.

Thus, endothelial

LDH release was monitored to assess cytotoxicity and changes in cell proliferation
were further studied by evaluating colony forming ability following treatment with
BaP or DMBA.

Results indicate that the concentrations of BaP and DMBA used in

these studies did not cause significant LDH release (overt cytotoxicity) at any time
after treatment. Thus, the failure of ECs to increase in cell number and the lack of
cytotoxicity suggest that proliferation is inhibited with chemical treatment.

Results

from the colony forming assay show that the ability of individual ECs to divide and
form colonies is significantly reduced with treatment of DMBA or BaP (Figure 13),
thus providing evidence that BaP and DMBA are capable of inhibiting endothelial cell
proliferation.

It was important to note that individual cells remained attached to the

plates in all treatment groups of this assay, suggesting that while replication was
inhibited, the lack of colony formation was not a result of cell mortality.
DNA synthesis and cellular protein content were evaluated in PAH treated ECs
to gain some initial insight into the intracellular changes that result from PAH
treatment and culminate in the inhibition of cell replication.

DNA synthesis was

determined following a growth arrest of monolayers such that cells were
synchronized into the same phase of the cell cycle. Results from BaP treated cells
show that cellular DNA synthesis increases in all treatment groups throughout the
first 48 hours when synchronized cells are in the S phase of the cell cycle.

Thymidine incorporation was significantly elevated in 0.01 µM BaP-treated cells at
24 and 48 hours, while thymidine incorporation was significantly decreased in 1 µM
BaP-treated cells at 24 hours.

These results suggest that there may be a

concentration threshold at which BaP induces different cellular responses; 0.01 µM
BaP may initiate DNA synthesis while 1 µM BaP may inhibit DNA synthesis, possibly
through alterations in the proteins which catalyze this process (Alberts et al.,
1994). The decrease in DNA synthesis in the 1 µM BaP treated cells may also affect
the triggering of signaling events which allows cells to proceed into the M phase of
the cell cycle, such that cell replication is inhibited. DNA synthesis decreases in all
BaP treatment groups between 48 hours and 96 hours. This decrease occurs as cell
numbers increase; DNA synthesis has been completed such that thymidine
incorporation returns to zero hour levels and cells have proceeded into the G2 phase
of the cell cycle. There is little fluctuation in DNA synthesis throughout the rest of
the experimental period in any of the treatment groups, although cell number
continues to increase in controls and 0.01 µM BaP-treated cells. This suggests that
cells may have become unsynchronized by 168 and 240 hours, such that any net
changes in DNA synthesis are not seen. It is also possible that at least part of the cell
population may have become quiescent by 168 and 240 hours.
Results from DMBA-treated cells show trends in DNA synthesis similar to
BaP-treated cells.

DNA synthesis decreases in all treatment groups throughout the

first 12 hours following synchronization, after which synthesis increases in all
treatment groups until 48 hours (Figure 12).

At 48 hours all treatment groups

show elevated DNA synthesis (significant in 0.01 µM DMBA treated cells) in
comparison to vehicle controls, suggesting that DMBA induces DNA replication. DNA
synthesis decreases in all treatment groups at 96 hours, although levels are
significantly higher in 0.01 and 0.1 µM DMBA-treated cells.

The decrease in
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synthesis in controls correlates to the increase in cell number at 96 hours, after
DNA synthesis has been completed and cells have completed the remainder of the cell
cycle.

However, cell numbers from 0.01 and 0.1 µM DMBA-treated cells are

decreased in comparison to controls. This suggests that prolonged exposure to low
concentrations of DMBA may stimulate DNA synthesis, although cells are unable to
complete the cycle and divide. These alterations in synthesis during the S phase of
the cell cycle may affect the signaling which allows cells to proceed into the M phase
where cytokinesis occurs (Alberts, 1994).

Damage to the DNA as a result of

chemical treatment may also inhibit cell cycle progression if damage is too extensive
for repair (Rogers and Kavlock, 1996). Synthesis continues to decrease throughout
the remainder of the experiment in all treatment groups. Again, this suggests that
cells may have become unsynchronized by 168 hours, such that any net changes in
DNA synthesis are not observed.

Our results are similar to those reported by

Zwijsen et al., (1990), where BaP was found to contribute to unscheduled DNA
synthesis in smooth muscle, culminating in a growth inhibitory response in situ.
Results from protein data suggest that BaP does not have any significant
effects on cellular protein content (Figure 9).

The changes in cellular protein

content throughout the 240 hour experimental period may be explained by cell
growth and division; cellular protein increases as cells grow and decreases following
division (Alberts et al., 1994).

Cellular protein in DMBA treated monolayers

decreased throughout the first 12 hours (Figure 10). At 24 hours, 0.01 µM DMBA
treated cells showed a significant decrease in protein content in comparison to
vehicle controls, while all other treatment groups increased in cellular protein
content. At 24 hours, 0.01 µM DMBA treated cells showed a decrease in protein,
while all other treatment groups showed an increase.

These changes in protein

content may be different from those induced by BaP. Results suggest that 0.01 µM
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DMBA treated cells may be inhibited in their ability to synthesize protein;
experiments to evaluate leucine or methionine incorporation could be done to prove
or disprove this hypothesis. This suggests that DMBA may induce at least some of its
effects on mRNA synthesis or on protein synthesis at this concentration.

All

treatment groups showed an increase in cellular protein throughout 168 hours,
followed by a decrease at 240 hours which may be attributed to cell quiescence. 1
µM DMBA treated cells showed cellular protein levels to be significantly elevated in
comparison to controls at both 168 and 240 hours. This may be explained by the
increase in cell size that occurs with 1 µM DMBA treatment at 168 hours when cells
are incapable of dividing (Figure 6). Post-translational damage to cellular protein
as a result of PAH treatment may lead to the inactivation of some proteins thus
preventing the appropriate signaling necessary for cells to proceed into the M phase
of the cell cycle (Alberts et al., 1994). Additionally, phenotypic changes in cells and
extracellular matrix changes which occur in response to PAH treatment may affect
the cytoskeletal control of gene expression, thus inducing changes in protein content
(Alberts et al., 1994; Gimbrone et al., 1995).
The endothelium is known to be a critical factor in maintaining vascular
homeostasis. In addition to the regulation of permeability, hemostasis, vasoactivity
and vascular cell growth, the endothelium is also actively involved in the
inflammatory response, wound repair, vascular dysfunction and disease (van
Hinsberg, 1992). Atherosclerosis has been characterized in its early stages by lipid
accumulation within the vessel intima, which occurs as a result of altered
endothelial ultrastructure (i.e., increased permeability) and increased uptake of
LDL (Penn and Chisolm, 1994; Poumay and Ronveaux-Dupal, 1989; Guretski et al.,
1994).

If BaP and DMBA are capable of inducing proatherogenic changes in the

endothelium, one of these changes may be an increase in cellular uptake of modified
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LDL. Thus, we measured cellular LDL uptake for monolayers treated with BaP and
DMBA throughout a 168 hour experimental period (Figures 14 and 15).

Results

from BaP treatment showed a slight increase in LDL uptake at 24 hours in 1 µM BaP
treated cells and at 96 hours in 0.1 and 1 µM BaP treated cells. All BaP treatment
groups showed an increase in cellular LDL uptake at 168 hours in comparison to
controls; 1 µM BaP treated cells showed a significant increase. This data suggests
that BaP is capable of inducing an increase in LDL uptake with prolonged exposure
and increasing concentration of chemical. DMBA treatment showed a slight increase
in LDL uptake in all treatment groups at 24 and 48 hours; the increase in 1 µM
DMBA-treated cells at 48 hours was significant.

At 96 hours, all treatment groups

showed significant elevation in cellular LDL uptake in comparison to vehicle
controls. At 168 hours, 0.01 and 0.1 µM DMBA treated cells showed that LDL uptake
was increased in comparison to controls, although control levels were elevated in
comparison to those at previous time points. This data suggests that like BaP, DMBA
is capable of inducing an increase in EC uptake of LDL. DMBA, however, is capable of
inducing this response more quickly and with lower concentrations of chemical,
although effects are most substantial with prolonged exposure.

Holland and

coworkers (1992) and Penn and Chisolm (1994) have shown that increases in the
uptake of modified LDL occur due to an increase in endocytic activity. Holland et al.,
(1992) have shown that increased EC endocytosis of LDL is accompanied by
cytoskeletal remodeling with increased stress fiber formation; these changes may
further contribute to alterations in cellular function. It has also been shown that EC
are capable of being maintained in this new functional state and is consistent with the
concept of endothelial dysfunction (Holland et al., 1992).

This increase in LDL

uptake may in turn induce signaling for monocyte recruitment and adhesion in
addition to altering cell migration and growth (Penn and Chisolm, 1994), thus
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further contributing to vascular injury.
While these findings provide some initial information on the endothelial
response to BaP and DMBA, they have not addressed the issue of LDL oxidation and the
effects on cellular uptake. LDL oxidation is a key factor in the atherogenic process
(Alexander et al., 1991; Penn and Chisolm, 1994), and the ability of BaP or DMBA
to generate reactive oxygen species that oxidize LDL may be important in
determining if the findings from this study are truly indicative of proatherogenic
changes.

It is of interest to determine the extent to which BaP or DMBA may induce

LDL oxidation; an increase in LDL uptake may be explained in part by oxidation as
there are several receptor-mediated pathways through which modified LDL can be
internalized in the endothelium, while native LDL is thought to be recognized only by
the B/E LDL receptor (Penn and Chisolm, 1994). Oxidized LDL has also been shown
to be chemotactic for monocytes and SMC, but is inhibitory to EC migration (Penn
and Chisolm 1994).

Additionally, oxidized LDL has been shown to have direct

cytotoxic effects on the endothelial monolayer (Alexander et al., 1991), such that
LDL modification may play a significant role in inducing and/or prolonging
endothelial dysfunction.
Endothelial injury resulting in focal cell detachment and alterations in
proliferation may result in an increase in the permeability of the monolayer, thus
allowing the passage and accumulation of various macromolecules into the
subendothelial space (DiCorleto and Chisolm, 1986; van Hinsberg, 1992; Coomber
and Gottlieb, 1990).

Monolayers under repair have been also been found to have

increased permeability (Coomber and Gottlieb, 1990).

It was thus expected that

endothelial injury as a result of BaP or DMBA treatment might induce an increase in
monolayer permeability. Such changes would correlate to atherogenic changes, as an
increase in monolayer permeability to macromolecules such as LDL and monocytes
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are some of the first occurrences in lesion development. Preliminary results from
monolayers treated with BaP or DMBA show that the monolayer permeability of
vehicle controls did not change much throughout the 168 hour experimental period
(Figures 16 and 17). Monolayers treated with 1 µM BaP mirrored the changes seen
in controls, with the exception of the 96 hour measurements.

At 96 hours,

monolayer permeability appears to be increased in 1 µM BaP treated cells.
However, the variability in monolayer response at this time point suggests that this
increase may not be real; further investigation will be necessary to prove or
disprove the validity of this increase. 1 µM DMBA treated monolayers showed trends
in monolayer permeability to be similar to controls.

At 48 hours, 1 µM DMBA

treated monolayers showed an increase in permeability, although again the large
variability suggests that this increase is not real. Therefore, it appears that BaP and
DMBA do not affect monolayer permeability although this does not mean that these
chemicals are incapable of playing a role in atherogenesis. It is possible that longer
treatment periods are required for substantial effects on permeability, or that a
model which more closely mimics an in vivo situation is required (i.e., a co-culture
system including smooth muscle cells and endothelium) in order to better evaluate
the effects of PAH treatment on monolayer permeability.
Focal monocyte adherence to the endothelium and subsequent migration into
the subendothelial space are observed in the first stages of atherosclerosis (Farqi
and DiCorleto, 1993; Takahashi et al., 1994).

If PAH treatment enhances this

process, it might be a way in which these chemicals contribute to the development of
atherosclerosis. Thus, monocyte adherence to endothelial monolayers treated with
BaP and DMBA was monitored throughout a 168 hour experimental period (Figures
18 and 19).

Preliminary results showed little change in monocyte adherence in

response to BaP or DMBA treatment at 24 hours in comparison to controls. At 48
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hours, 0.01 and 0.1 µM BaP treated cells showed an increase in monocyte adherence
in comparison to vehicle controls, while DMBA-treated cells showed an increase in
adherence in all treatment groups.

At 96 hours, monocyte adherence was not

elevated in comparison to controls in any BaP treatment group, while all DMBA
treatment groups showed an increase in adherence. All BaP treatment groups showed
an increase in monocyte adherence at 168 hours in comparison to controls, while
DMBA-treated cells only showed an increase with 0.01 or 0.1 µM DMBA. This data
suggests that BaP and DMBA are capable of inducing an increase in EC monocyte
adherence with increasing concentration and prolonged exposure. Further work will
need to be done in order to determine if these results are reproducible. Increased
monocyte adherence at 48 hours, 96 hours, and 168 hours may be due to elevated
endothelial expression of ICAM-1 and/or VCAM-1 in response to chemical exposure.
Both of these adhesion molecules are induced within 12 to 48 hours following
stimulation (Beekhuizen and van Furth, 1993). ICAM-2 may not play a role in this
process as it is constitutively expressed (Beekhuizen and van Furth, 1993), and
results indicate that there is no increase in adherence at 24 hours with BaP or DMBA
treatment; however it is possible that the expression of this adhesion molecule is
upregulated with PAH treatment. Both P-selectin and E-selectin may have a role in
tethering the monocytes to PAH-treated endothelium (Beekhuizen and van Furth,
1993).

Further studies will need to be done to determine which of the adhesion

molecules are involved in PAH induced monocyte adhesion to ECs. It is possible that a
more complex model is necessary to accurately assess PAH induced changes in
monocyte adherence because it is a multifactorial process, relying on the activation
of both endothelial cells and monocytes.

However, the results do provide initial

evidence which supports the hypothesis that BaP and DMBA are capable of inducing a
change in the endothelium with time and prolonged exposure which may be indicative
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of a shift towards a proatherogenic state.
While descriptive and non-mechanistic, this study has provided valuable
information on the concentration/response relationships between PAHs and the
endothelium. Data from general toxicity assays in this study have defined the dose
and length of PAH exposure which is necessary to induce an endothelial response.
This study has demonstrated that these chemicals are capable of altering cell
proliferation and cell function (including LDL uptake and monocyte adherence)
without inducing acute cytotoxicity. Thus, it appears that BaP and DMBA could play a
role in prolonged endothelial cell dysfunction and possibly in the initiation and/or
promotion of the atherogenic process.

Atherogenesis is considered to be a

multifactorial process which occurs in response to some form of vascular injury.
The cultured endothelium is a useful model for the study of vascular injury, although
it is simplistic.

Thus, the preliminary information obtained from this study must be

interpreted carefully with regard to the ability of BaP and DMBA to induce
atherogenic changes. Analysis of results from this study suggest that although PAHs
did not induce large, overt changes in cell function, they did perhaps induce effects
which may play a role in prolonged vascular injury and the initiation or promotion
of atherosclerosis.
In conclusion, this study is the first to have demonstrated the effects of BaP
and DMBA on the vascular endothelium with regard to cell toxicity and functional
alterations.

Better understanding of the effects that BaP and DMBA, as

environmental contaminants and components of cigarette smoke, have on the
endothelium may help to further elucidate the processes by which vascular disease
develops.

There are several approaches which may be used to further our

understanding of PAH toxicity and vascular injury. Additional studies using ECs in
co-culture with SMC may provide information which more accurately mimics an in

vivo situation. Other studies may also examine specific changes in the expression of
adhesion molecules, both on the endothelium and on monocytes, in response to PAH
treatment.

Determining the role of PAHs in the generation of reactive oxygen

intermediates (ROls) as well as their role in the EC changes observed in this study
may provide additional information about PAH induced vascular injury. Additionally,
the assays used in this study could be repeated following treatment with PAHs given
in an initiation-promotion sequence with a known initiator or promotor of
atherosclerosis. This may help to determine if PAHs are capable of inducing more
profound endothelial effects when acting as an initiator or a promotor of
atherosclerosis as opposed to a complete atherogen.
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